登记状态:
注销
注册资本:
15万美元
成立时间:
2007-03-13
法定代表人:
若冰
招聘概况:
近3个月无招聘
The George Institute for Global Health
The George Institute for Global Health was established in 1999 as an
independent not-for-profit organisation dedicated to the prevention and
management of non-communicable diseases and injury, through domestic
and international programs.
The George Institute has grown rapidly since its inception, and
currently employs approximately 350 people globally with 200 staff
located at its headquarters in Sydney.
The George Institute manages numerous large-scale international and
regional trials and projects funded by a diverse range of sponsors,
both public and private. The research portfolio of the institute
includes randomized trials of new treatment and prevention strategies,
surveys, and observational studies of the causes and outcomes of
disease and injury. The current research budget of the Institute is
approximately $25-30 million per year. Research revenue comes from
national and international medical research agencies, private sponsors
and industry.
Clinical research trials and operations are conducted at approximately
600 centres in more than 30 countries worldwide. While Asia is a major
focus, the George Institute is also active throughout Europe, North
America, and Australasia. The George Institute has offices in Sydney,
Hyderabad, London and Beijing.
The George Institute also provides strategic consulting and operational
services to external clients in the biotechnology and pharmaceutical
industries.
The George Institute is dedicated to the recruitment, development, and
retention of the best people from around the world. The pursuit of
academic, scientific and operational excellence in a “can do” culture
is actively promoted in all our activities.
Context
The Goerge Institute for Global Health, China (GIC) aims to facilitate
the sharing of knowledge, information and ideas, and skills across all
areas of clinical research, training, teaching, clinical practice, and
policy development with our partners in China. The ultimate goal is a
sustained commitment to the implementation of evidence-based policy and
practice that addresses the burden of disease.
Diabetes Research (DR) is a new erected section in GIC. The key role of
DR team is to support the development and implementation of high
quality projects / initiatives in diabetes in China. The team member
will participate in all phases of project development, providing advice
on concept development, project management structures, logistics,
capacity development activities, potential funding sources, media
relations, and strategies for the dissemination of research findings to
facilitate uptake into practice. Studies cover the area of
epidemiology, prevention, health care and management, treatment and
health economy on diabetes.
In collaboration with IDF (International Diabetes Federation) and CDS
(Chinese Diabetes Society), several large-scale investigation projects
have been launched to assess the incidence, care, treatment and cost of
diabetes mellitus in China. Hundreds of health care facilities have
been covered in these studies. Talents have academic study background
are welcome to join the team.
更多